Carotid intima-media thickness measured by ultrasonography: Effect of different pharmacotherapies on atherosclerosis progression;Az ultrahanggal mért arteria carotis intima-media vastagság: A különbözo gyógyszerek hatása az atherosclerosis progressziójára

Orvosi Hetilap

Volumn 146, Issue 23, 2005, Pages 1239-1244

  Csiba, László ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b NONE   (Hungary)

Author keywords

Antihypertensive therapy; Atherosclerosis; B mode ultrasound; Coronary heart disease; Hypertension; Intima media thickness; Lipid lowering therapy; Statin; Stroke prevention

Indexed keywords

ALPHA TOCOPHEROL; AMILORIDE PLUS HYDROCHLOROTHIAZIDE; AMLODIPINE; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ASCORBIC ACID; ATENOLOL; ATORVASTATIN; COLESTIPOL; ENALAPRIL; ESTRADIOL; ETHINYLESTRADIOL PLUS GESTODENE; FLUINDOSTATIN; HYDROCHLOROTHIAZIDE; ISRADIPINE; LISINOPRIL; LOSARTAN; METOPROLOL; MEVINOLIN; NICOTINIC ACID; NIFEDIPINE; PRAVASTATIN; RAMIPRIL; SIMVASTATIN; CARDIOVASCULAR AGENT;

ATHEROSCLEROSIS; CAROTID ARTERY; CLINICAL FEATURE; DISEASE COURSE; DRUG FORMULATION; ECHOGRAPHY; FOLLOW UP; HUMAN; INTIMA; MORBIDITY; MORTALITY; REVIEW; RISK FACTOR; CAROTID ARTERY OBSTRUCTION; DRUG EFFECT; PATHOLOGY; TUNICA MEDIA;

ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; ASCORBIC ACID; CARDIOVASCULAR AGENTS; CAROTID ARTERIES; CAROTID STENOSIS; DISEASE PROGRESSION; ESTRADIOL; HUMANS; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA; VITAMIN E;

EID: 22144452533     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Angerer, P., Stork, S., Kothny, W. és mtsai: Effect of oral postmenopausal hormone replacement on progression of atherosclerosis: a randomized, controlled trial. Arterioscler Thromb. Vasc. Biol., 2001, 21, 262-8.
2. Barth, J. D.: An update on carotid ultrasound measurement of intima-media thickness. Am. J. Cardiol., 2002, 89, 32B-38B.
3. Baldassarre, D., Veglia, F., Gobbi, C. és mtsai: Intima-media thickness after pravastatin stabilizes also in patients with moderate to no reduction in LDL-cholesterol levels: the carotid atherosclerosis Italian ultrasound study. Atherosclerosis, 2000, 151, 575-583.
4. Bisoendial, R. J., Hovingh, G. K., de Groot, E. és mtsai: Measurement of subclinical atherosclerosis: beyond risk factor assessment. Curr. Opin. Lipidol., 2002, 13, 595-603.
5. Boutouyrie, P., Bussy, C., Tropeano, A. I. és mtsai: Local pulse pressure and regression of arterial wall hypertrophy during antihypertensive treatment. CELIMENE study. The Celiprolol Intima-Media Enalapril Efficacy study. Arch. Mal. Coeur. Vaiss., 2000, 93, 911-915.
6. Byington, R. P., Furberg, C. D., Crouse, J. R. 3rd és mtsai: Pravastatin, Lipids, and Atherosclerosis in the Carotid Arteries (PLAC-II). Am. J. Cardiol., 1995, 76, 54C-59C.
7. Blum, A.: Volumic and multislice CT: principles, applications and future prospects. JBR-BTR, 2002, 85, 82-99.
8. Borhani, N. O., Mercuri, M., Borhani, P. A. és mtsai: Final outcome results of the Multicenter Isradipine Diuretic AtherosclerosisvStudy (MIDAS). A randomized controlled trial. JAMA, 1996, 276, 785-791.
9. Bots, M. L., Hoes, A. W., Koudstaal, P. J. és mtsai: Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation, 1997, 96, 1432-7.
10. Bots, M. L.: Grobbee DE. Intima media thickness as a surrogate marker for generalised atherosclerosis. Cardiovasc. Drugs. Ther., 2002, 16, 341-351.
11. Budoff, M. J.: Atherosclerosis imaging and calcified plaque: coronary artery disease risk assessment. Prog. Cardiovasc. Dis., 2003, 46, 135-148.
12. Chambless, L. E., Folsom, A. R., Clegg, L. X. és mtsai: Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am. J. Epidemiol., 2000, 151, 478-487.
13. Crouse, J. R. 3rd, Grobbee, D. E., O'Leary, D. H. és mtsai: Measuring Effects on intima media Thickness: an Evaluation Of Rosuvastatin in subclinical atherosclerosis -the rationale and methodology of the METEOR study. Cardiovasc. Drugs. Ther., 2004, 18, 231-238.
14. de Groot, E., Jukema, J. W., Montauban van Swijndregt, A. D. és mtsai: B-mode ultrasound assessment of pravastatin treatment effect on carotid and femoral artery walls and its correlations with coronary arteriographic findings: a report of the Regression Growth Evaluation Statin Study (REGRESS). J. Am. Coll. Cardiol., 1998, 31, 1561-1567.
15. Fayad, Z. A., Sirol, M., Nikolaou, K. és mtsai: Magnetic resonance imaging and computed tomography in assessment of atherosclerotic plaque. Curr. Atheroscler. Rep., 2004, 6, 232-242.
16. Furberg, C. D., Adams, H. P. Jr., Applegate, W. B. és mtsai: Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group. Circulation, 1994, 90, 1679-1687.
17. Gariepy, J., Simon, A., Chironi, G. és mtsai: Large artery wall thickening and its determinants under antihypertensive treatment: the IMT-INSIGHT study. J. Hypertens., 2004, 22, 137-43.
18. Gotto, A. M. jr., Farmer, J. A.: Pleiotropic effect of statins:Do they matter? Curr. Opin. Lipidol., 2001, 12, 391-394.
19. Haller, H., Cosentino, F., Luscher. T. F.: Endothelial dysfunction, hypertension and atherosclerosis. A review of the effects of lacidipine. Drugs. R. D., 2002, 3, 311-323.
20. Hedblad, B., Wikstrand, J., Janzon, L. és mtsai: Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation, 2001, 103, 1721-1726.
21. Hodis, H. N., Mack, W. J., LaBree, L. és mtsai: Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann. Intern. Med., 1996, 124, 548-56.
22. Kodama, M., Yamasaki, Y., Sakamoto, K. és mtsai: Antiplatelet drugs attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes. Thromb. Res., 2000, 97, 239-245.
23. Lonn, E., Yusuf, S., Dzavik, V. és mtsai: SECURE Investigators. Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE). Circulation, 2001, 103, 919.
24. Ludwig, M., Stapff, M., Ribeiro, A. és mtsai: Comparison of the effects of losartan and atenolol on common carotid artery intima-media thickness in patients with hypertension: results of a 2-year, double-blind, randomized, controlled study. Clin Ther., 2002, 24, 1175-1193.
25. Ludwig, M., von Petzinger-Kruthoff, A., von Buquoy, M. és mtsai: Intima media thickness of the carotid arteries: early pointer to arteriosclerosis and therapeutic endpoint. Ultraschall. Med., 2003, 24, 162-174.
26. Mack, W. J., Hameed, A. B., Xiang, M. és mtsai: Does elevated body mass modify the influence of postmenopausal estrogen replacement on atherosclerosis progression: results from the estrogen in the prevention of atherosclerosis trial. Atherosclerosis, 2003, 168, 91-98.
27. MacMahon, S., Sharpe, N., Gamble, G. és mtsai: Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. Circulation, 1998, 97, 1784-1790.
28. Mancini, G. B.: Carotid intima-media thickness as a measure of vascular target organ damage. Curr Hypertens Rep., 2000, 2, 71-77.
29. Mancini, G. B.: Overview of the prospective randomized evaluation of the vascular effects of Norvasc (amlodipine) trial: PREVENT. Can. J. Cardiol., 2000, 16 (Suppl.), 5D-7D.
30. Magyar, M. T., Paragh, G., Katona, E. és mtsai: Serum cholesterols have a more important role than triglycerides in determining intima-media thickness of the common carotid artery in subjects younger than 55 years of age. J. Ultrasound. Med., 2004 23, 1161-1169.
31. Mercuri, M., Bond, M. G., Sirtori, C. R. és mtsai: Pravastatin reduces carotid intima-media thickness progression in an asymptomatic hypercholesterolemic mediterranean population: the Carotid Atherosclerosis Italian Ultrasound Study. Am. J. Med., 1996, 101, 627-634.
32. Migdalis, I. N., Gerolimou, B., Kozanidou, G. és mtsai: Effect of gemfibrozil on early carotid atherosclerosis in diabetic patients with hyperlipidaemia. Int. Angiol., 1997, 16, 258-261.
33. O'Leary, D. H., Polak, J. F., Kronmal, R. A. és mtsai: Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med., 1999, 340, 14-22.
34. Páll, D., Settakis, G., Katona, E. és mtsai: Debrecen Hypertension Study. Increased common carotid artery intima media thickness in adolescent hypertension: results from the Debrecen Hypertension study. Cerebrovasc Dis., 2003, 15, 167-172.
35. Patel, S. G., Collie, D. A., Wardlaw, J. M. és mtsai: Outcome, observer reliability, and patient preferences if CTA, MRA, or Doppler ultrasound were used, individually or together, instead of digital subtraction angiography before carotid endarterectomy. J. Neurol. Neurosurg. Psychiatry, 2002, 73, 21-28.
36. Pitt, B., Byington, R. P., Furberg, C. D. és mtsai: Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation, 2000, 102, 1503-1510.
37. Rothwell, P. M.: Carotid artery disease and the risk of ischaemic stroke and coronary vascular events. Cerebrovasc. Dis., 2000, 10, 21-33.
38. Salonen, R., Nyyssonen, K., Porkkala, E. és mtsai: Kuopio Atherosclerosis Prevention Study (KAPS). A population-based primary preventive trial of the effect of LDL lowering on atherosclerotic progression in carotid and femoral arteries. Circulation, 1995, 92, 1758-1764.
39. Simon, A., Gariepy, J., Chironi, G. és mtsai: Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. J. Hypertens., 2002, 20, 159-169.
40. Smilde, T. J., van Wissen, S., Wollersheim, H. és mtsai: Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective, randomised, double-blind trial. Lancet, 2001, 357, 577-581.
41. Stanton, A. V., Chapman, J. N., Mayet, J. és mtsai: Effects of blood pressure lowering with amlodipine or lisinopril on vascular structure of the common carotid artery. Clin. Sci. (Lond), 2001, 101, 455-464.
42. Taddei, S., Ghiadoni, L., Salvetti, A.: Current treatment of patients with hypertension: therapeutic implications of INSIGHT. Drugs., 2003, 63, 1435-1444.
43. Taylor, A. J., Sullenberger, L. E., Lee, H. J. és mtsai: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins. Circulation, 2004, 110, 3512-3517.
44. Terpstra, W. F., May, J. F., Smit, A. J. és mtsai: Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial. J. Hypertens., 2004, 22, 1309-1316.
45. van Wissen, S., Smilde, T. J., de Groot, E. és mtsai: The significance of femoral intima-media thickness and plaque scoring in the Atorvastatin versus Simvastatin on Atherosclerosis Progression (ASAP) study. Eur. J. Cardiovasc. Prev. Rehabil., 2003, 10, 451-455.
46. Wikstrand, J., Berglund, G., Hedblad, B. és mtsai: Antiatherosclerotic effects of beta-blockers. Am. J Cardiol., 2003, 91, 25H-29H.
47. Zanchetti, A., Crepaldi, G., Bond, M. G. és mtsai: Systolic and pulse blood pressures (but not diastolic blood pressure and serum cholesterol) are associated with alterations in carotid intima-media thickness in the moderately hypercholesterolaemic hypertensive patients of the Plaque. Hypertension Lipid Lowering Italian Study. PHYLLIS study group. J. Hypertens., 2001, 19, 79-88.
48. Zanchetti, A., Rosei, E. A., Dal Palu, C. és mtsai: The Verapamil in Hypertension and Atherosclerosis Study (VHAS): results of long-term randomized treatment with either verapamil or chlorthalidone oncarotid intima-media thickness. J. Hypertens., 1998, 16, 1667-1676.
49. Zanchetti, A., Bond, M. G., Hennig, M. és mtsai: European Lacidipine Study on Atherosclerosis investigators. Calcium antagonist lacidipine slows down progression of asymptomatic carotidatherosclerosis: principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial. Circulation, 2002, 106, 2422-2427.